Automate and Accelerate Patient Recruitment with Clinithink at DIA 2017
Visit booth 2448 at this years' DIA Annual Meeting from June 18-22 in Chicago, IL and find out more about how Clinithink is creating a paradigm shift in patient enrollment for clinical trials.
Clinithink is exhibiting at DIA, the largest, longest-running event in the life sciences industry, to demonstrate how searching clinical narrative data in patient records markedly accelerates the rate at which patients are identified and enrolled into clinical trials.
The exhibiting team invites DIA attendees from across the life sciences industry to visit booth 2448 to find out more about how Clinithink's market-leading Artificial Intelligence (AI) technology is creating a paradigm shift in patient enrollment using existing, available, real-world data. Clinithink's CLiX accelerate solution largely automates the pre-screening process, drastically reducing the time and cost of this critical part of the clinical trial process. Using the solution, investigators at Mount Sinai and elsewhere have demonstrated a 10-fold increase in pre-screening yield and enrollment rate. CLiX accelerate is effective for both common and rare disease clinical trials.
On attending DIA 2017, Clinithink CEO, Dr Chris Tackaberry, said, "We are excited to be part of the most anticipated life sciences event of the year and demonstrate how using CLiX accelerate is transforming the clinical trials landscape by accelerating patient enrollment, and offering data-driven insights into feasibility."
Now in its 53rd year, this years' theme is: ‘Driving Insights to Action’ and will host 7,000 global healthcare professionals in the pharmaceutical, biotechnology, and medical device communities expected to attend from more than 51 countries. More information about DIA 2017 can be found here.
Visit us at Booth 2448 and get the answers to your patient enrollment challenges!